Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

Cannabidiol (CBD)

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-06-15 — CBD for Individuals at Risk for Alzheimer’s Disease: Double-blind RCT launching (design/aims only, no readout) in individuals at risk for Alzheimer’s disease, testing CBD against validated AD progression biomarkers plus behavioral, neurocognitive, and clinical measures. [human-rct] (novelty: 3)

Open questions

Related

Contributing findings

clinicaltrials trial early human-rct
CBD for Individuals at Risk for Alzheimer's Disease
15-jun-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18